The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malaria

Science Translational Medicine · Published 2026-06-10 · DOI 10.1126/scitranslmed.aec1863

Free full text

Authors (29)

Bridget E. Barber, Robin Denhardt-Eriksson, Etienne A. Guirou, Julia Flynn, Nischal Sahai, Indika Leelasena, Susan Mathison, Chris Moller, Ivan Lim, Carla Evangelista, Rebecca Webster, Adam J. Potter, Stacey Llewellyn, Fiona H. Amante, Jeremy Gower, Jenny Peters, David S. Khoury, Vandana Thathy, Sunil K. Narwal, Tomas Yeo, David A. Fidock, Michael W. Marx, Francisco-Javier Gamo, Raman Sharma, Rachel A. Gibson, Laura Sanz, Anthony Cahn, Benoit Bestgen, Stephan Chalon

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Barber, B., Denhardt-Eriksson, R., Guirou, E., et al. (2026). The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malaria. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aec1863

Related articles